Companies: 10,795·Total market cap: $144.5T
Arena Pharmaceuticals, Inc.

Arena Pharmaceuticals, Inc.

ARNANASDAQHealthcare
$99.99
+$0.00(+0.00%)
Market Cap$0
P/E Ratio
52W High$100
52W Low$99.97
Overview

Arena Pharmaceuticals, Inc.(ARNA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ARNA · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2021-122020-122019-122018-122017-12
Revenue
Revenue$0.05M$0.32M$806.43M$17.97M$21.34M
Cost of Revenue$0.00M$0.00M$0.00M$0.00M$0.00M
Gross Profit$0.05M$0.32M$806.43M$17.97M$21.34M
Gross Margin %(computed)100.00%100.00%100.00%100.00%100.00%
Operating Expenses
R&D Expenses$419.51M$323.74M$231.50M$115.03M$70.99M
G&A Expenses$126.20M$103.20M$77.60M$47.70M$30.30M
Total Operating Expenses$554.35M$426.94M$323.67M$162.73M$101.29M
Operating Income($612.27M)($426.64M)$482.75M($144.78M)($91.97M)
Operating Margin %(computed)59.86%-805.69%-431.02%
Interest Income$1.43M$11.05M$26.87M$8.77M$0.49M
Interest Expense$4.16M$4.52M$4.79M$5.70M$6.12M
Income Before Tax($616.43M)($404.73M)$507.89M($138.83M)($95.81M)
Income Tax Expense$4.16M$0.00M$110.33M($110.27M)$2.27M
Net Income($620.59M)($404.73M)$397.56M($29.40M)($91.41M)
Net Margin %(computed)49.30%-163.60%-428.40%
Per Share & EBITDA
EPS (Basic)$-11.33$-7.39$7.69$-0.62$-2.77
Wtd Avg Shares54.77M54.77M51.70M47.04M32.99M
EBITDA($608.40M)($396.35M)$515.91M($130.21M)($81.01M)
EBITDA Margin %(computed)63.97%-724.60%-379.67%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Arena Pharmaceuticals, Inc.

关于Arena Pharmaceuticals, Inc.(ARNA)损益表

Arena Pharmaceuticals, Inc.(ARNA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2021财年,ARNA实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.62B)(净利率-1149244.44%)。

常见问题

ARNA · 4 问

Arena Pharmaceuticals, Inc.(ARNA)2021财年营收为$0.00B,同比down83.1%。

ARNA revenueARNA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09